rss
Evid Based Med 19:e14 doi:10.1136/eb-2013-101580
  • Therapeutics
  • Randomised controlled trial

Gastric bypass surgery is more efficacious than intensive lifestyle and medical treatment for type 2 diabetes remission

  1. David Arterburn2
  1. 1Kaiser Center for Health Research, Atlanta, Georgia, USA;
  2. 2Group Health Research Institute, Seattle, Washington, USA
  1. Correspondence to: Dr David Arterburn
    , Group Health Research Institute, 1730 Minor Ave, Suite 1600 Seattle, WA 98108, USA; arterburn.d{at}ghc.org

Commentary on:

Context

Despite numerous medication and lifestyle treatment options, just over half of patients with type 2 diabetes mellitus (T2DM) achieve a glycated haemoglobin (HbA1c) of <7%.1 Roux-en-y gastric bypass surgery (RYGB) has traditionally been reserved for treating severe obesity, but there is growing interest in using this and other bariatric procedures to treat T2DM in less obese patients.2 ,3 There have been few rigorous studies comparing RYGB against best available non-surgical treatment for control of T2DM and comorbid conditions.

Methods

Ikramuddin and colleagues conducted a …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBM.
View free sample issue >>


Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article